Stay updated on Efgartigimod in Post-COVID-19 POTS Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.

Latest updates to the Efgartigimod in Post-COVID-19 POTS Clinical Trial page
- Check2 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, representing a newer version of the page's template or metadata. No substantive study details, eligibility criteria, or results appear to be changed.SummaryDifference0.0%

- Check9 days agoChange DetectedLinks and metadata for study documents were added, including PDF versions of the Statistical Analysis Plan and Study Protocol, along with notes on IPD plans and related MeSH terms. These updates provide researchers with direct access to the study's methodology and regulatory context.SummaryDifference63%

- Check16 days agoChange DetectedRevision: v3.6.0 was added. Several study documents and metadata (PDFs, protocols, IPD plans, collaborators) were removed from the study record.SummaryDifference18%

- Check23 days agoChange DetectedThe page shows a revision update from v3.5.4 to v3.5.5, representing an internal software or content-management update. This does not alter the information presented about the study or its navigation.SummaryDifference0.0%

- Check44 days agoChange DetectedVersion label updated from v3.5.3 to v3.5.4, indicating a minor platform update. There are no evident changes to the study details or page content.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page’s footer/version indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a background site update rather than a change to the clinical trial information.SummaryDifference0.0%

Stay in the know with updates to Efgartigimod in Post-COVID-19 POTS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.